Filing Details
- Accession Number:
- 0000014272-22-000174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-22 17:12:23
- Reporting Period:
- 2022-09-20
- Accepted Time:
- 2022-09-22 17:12:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1533201 | Giovanni Caforio | Bristol-Myers Squibb Company 430 E. 29Th Street, 14 Floor New York NY 10016 | Board Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2022-09-20 | 25,000 | $69.71 | 476,104 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021.
Billionaire Hedge Funds
